The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD‐L1 for Enhanced Cancer Immunotherapy
Abstract
Cuproptosis is a new cell death that depends on copper (Cu) ionophores to transport Cu into cancer cells, which induces cell death. However, existing Cu ionophores are small molecules with a short blood half‐life making it hard to transport enough Cu into cancer cells. Herein, a reactive oxygen species (ROS)‐sensitive polymer (PHPM) is designed, which is used to co‐encapsulate elesclomol (ES) and Cu to form nanoparticles (NP@ESCu). After entering cancer cells, ES and Cu, triggered by excessive intracellular ROS, are readily released. ES and Cu work in a concerted way to not only kill cancer cells by cuproptosis, but also induce immune responses. In vitro, the ability of NP@ESCu to efficiently transport Cu and induce cuproptosis is investigated. In addition, the change in the transcriptomes of cancer cells treated with NP@ESCu is explored by RNA‐Seq. In vivo, NP@ESCu is found to induce cuproptosis in the mice model with subcutaneous bladder cancer, reprograming the tumor microenvironment. Additionally, NP@ESCu is further combined with anti‐programmed cell death protein ligand‐1 antibody (αPD‐L1). This study provides the first report of combining nanomedicine that can induce cuproptosis with αPD‐L1 for enhanced cancer therapy, thereby providing a novel strategy for future cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx247 · Cited by 9,849
Copper induces cell death by targeting lipoylated TCA cycle proteins
Tsvetkov, P., Coy, S., Petrova, B., Dreishpoon, M., Verma, A., Abdusamad, M., Rossen, J., Joesch-Cohen, L., Humeidi, R., Spangler, R. D., et al. (2022) · Science · doi:10.1126/science.abf0529 · Cited by 4,932
Macrophages as tools and targets in cancer therapy
Mantovani, A., Allavena, P., Marchesi, F., & Garlanda, C. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00520-5 · Cited by 1,807
Copper homeostasis and cuproptosis in health and disease
Chen, L., Min, J., & Wang, F. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01229-y · Cited by 1,493
Connecting copper and cancer: from transition metal signalling to metalloplasia
Ge, E. J., Bush, A. I., Casini, A., Cobine, P. A., Cross, J. R., DeNicola, G. M., Dou, Q. P., Franz, K. J., Gohil, V. M., Gupta, S., et al. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00417-2 · Cited by 1,298
Cuproptosis: a copper-triggered modality of mitochondrial cell death
Tang, D., Chen, X., & Kroemer, G. (2022) · Cell Research · doi:10.1038/s41422-022-00653-7 · Cited by 960
Tong, X., Tang, R., Xiao, M., Xu, J., Wang, W., Zhang, B., Liu, J., Yu, X., & Shi, S. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01392-3 · Cited by 883
Self-citationGalsky, M. D., Arija, J. Á. A., Bamias, A., Davis, I. D., De Santis, M., Kikuchi, E., Garcia-del-Muro, X., De Giorgi, U., Mencinger, M., Izumi, K., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30230-0 · Cited by 786
Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer
Oh, D. Y., Kwek, S. S., Raju, S. S., Li, T., McCarthy, E., Chow, E., Aran, D., Ilano, A., Pai, C.-C. S., Rancan, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.017 · Cited by 734
Mitochondrial metabolism promotes adaptation to proteotoxic stress
Tsvetkov, P., Detappe, A., Cai, K., Keys, H. R., Brune, Z., Ying, W., Thiru, P., Reidy, M., Kugener, G., Rossen, J., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0291-9 · Cited by 645
Powles, T., Csőszi, T., Özgüroğlu, M., Matsubara, N., Géczi, L., Cheng, S. Y.-S., Fradet, Y., Oudard, S., Vulsteke, C., Morales Barrera, R., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00152-2 · Cited by 643
Kahlson, M. A., & Dixon, S. J. (2022) · Science · doi:10.1126/science.abo3959 · Cited by 521
Cuproptosis: a new form of programmed cell death
Wang, Y., Zhang, L., & Zhou, F. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-022-00866-1 · Cited by 444
Self-citationXu, Y., Liu, S., Zeng, L., Ma, H., Zhang, Y., Yang, H., Liu, Y., Fang, S., Zhao, J., Xu, Y., et al. (2022) · Advanced Materials · doi:10.1002/adma.202204733 · Cited by 419
Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion
Voli, F., Valli, E., Lerra, L., Kimpton, K., Saletta, F., Giorgi, F. M., Mercatelli, D., Rouaen, J. R. C., Shen, S., Murray, J. E., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0471 · Cited by 411
Cuproptosis: Cellular and molecular mechanisms underlying copper-induced cell death
Cobine, P. A., & Brady, D. C. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.05.001 · Cited by 411
Nagai, M., Vo, N. H., Shin Ogawa, L., Chimmanamada, D., Inoue, T., Chu, J., Beaudette-Zlatanova, B. C., Lu, R., Blackman, R. K., Barsoum, J., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.03.017 · Cited by 357
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
Zheng, P., Zhou, C., Lu, L., Liu, B., & Ding, Y. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02485-0 · Cited by 352
Xu, W., Qian, J., Hou, G., Wang, T., Wang, J., Wang, Y., Yang, L., Cui, X., & Suo, A. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202205013 · Cited by 267
Photothermally Triggered Copper Payload Release for Cuproptosis‐Promoted Cancer Synergistic Therapy
Zhou, J., Yu, Q., Song, J., Li, S., Li, X., Kang, B., Chen, H., & Xu, J. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202213922 · Cited by 225
The multifaceted immune regulation of bladder cancer
Schneider, A. K., Chevalier, M. F., & Derré, L. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0226-y · Cited by 219
Byun, J.-K., Park, M., Lee, S., Yun, J. W., Lee, J., Kim, J. S., Cho, S. J., Jeon, H.-J., Lee, I.-K., Choi, Y.-K., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.10.015 · Cited by 208
Biomedical polymers: synthesis, properties, and applications
Chen, W.-H., Chen, Q.-W., Chen, Q., Cui, C., Duan, S., Kang, Y., Liu, Y., Liu, Y., Muhammad, W., Shao, S., et al. (2022) · Science China Chemistry · doi:10.1007/s11426-022-1243-5 · Cited by 187
Self-citationYu, Y., Tang, D., Liu, C., Zhang, Q., Tang, L., Lu, Y., & Xiao, H. (2022) · Advanced Materials · doi:10.1002/adma.202105976 · Cited by 186
Self-citationMacNabb, B. W., Chen, X., Tumuluru, S., Godfrey, J., Kasal, D. N., Yu, J., Jongsma, M. L. M., Spaapen, R. M., Kline, D. E., & Kline, J. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.016 · Cited by 181
Lanna, A., Vaz, B., D’Ambra, C., Valvo, S., Vuotto, C., Chiurchiù, V., Devine, O., Sanchez, M., Borsellino, G., Akbar, A. N., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00991-z · Cited by 178
Myeloid-Derived Suppressor Cells: A Propitious Road to Clinic
Grover, A., Sanseviero, E., Timosenko, E., & Gabrilovich, D. I. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0764 · Cited by 175
Biomedical applications of copper ionophores
Oliveri, V. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213474 · Cited by 169
X-ray structures of the high-affinity copper transporter Ctr1
Ren, F., Logeman, B. L., Zhang, X., Liu, Y., Thiele, D. J., & Yuan, P. (2019) · Nature Communications · doi:10.1038/s41467-019-09376-7 · Cited by 164
Kobatake, K., Ikeda, K., Nakata, Y., Yamasaki, N., Ueda, T., Kanai, A., Sentani, K., Sera, Y., Hayashi, T., Koizumi, M., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2230 · Cited by 156
Tang, D., Yu, Y., Zhang, J., Dong, X., Liu, C., & Xiao, H. (2022) · Advanced Materials · doi:10.1002/adma.202203820 · Cited by 151
Self-citationCompetitive glucose metabolism as a target to boost bladder cancer immunotherapy
Afonso, J., Santos, L. L., Longatto‐Filho, A., & Baltazar, F. (2020) · Nature Reviews Urology · doi:10.1038/s41585-019-0263-6 · Cited by 144
The dynamic roles of the bladder tumour microenvironment
Lee, Y., Lam, H., Rosser, C. J., Theodorescu, D., Parks, W. C., & Chan, K. S. (2022) · Nature Reviews Urology · doi:10.1038/s41585-022-00608-y · Cited by 131
Wang, L., Yu, Y., Wei, D., Zhang, L., Zhang, X., Zhang, G., Ding, D., Xiao, H., & Zhang, D. (2021) · Advanced Materials · doi:10.1002/adma.202100599 · Cited by 129
Self-citationJia, W., Tian, H., Jiang, J., Zhou, L., Li, L., Luo, M., Ding, N., Nice, E. C., Huang, C., & Zhang, H. (2022) · Small · doi:10.1002/smll.202205354 · Cited by 100
Zhang, L., Wang, Y., Karges, J., Tang, D., Zhang, H., Zou, K., Song, J., & Xiao, H. (2022) · Advanced Materials · doi:10.1002/adma.202210267 · Cited by 99
Self-citationDing, F., Li, F., Tang, D., Wang, B., Liu, J., Mao, X., Yin, J., Xiao, H., Wang, J., & Liu, Z. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202203546 · Cited by 84
Self-citationZinc and Copper Levels in Bladder Cancer: A Systematic Review and Meta-Analysis
Mao, S., & Huang, S. (2013) · Biological Trace Element Research · doi:10.1007/s12011-013-9682-z · Cited by 74
Zhang, L., Shang, K., Li, X., Shen, M., Lü, S., Tang, D., Han, H., & Yu, Y. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202204589 · Cited by 65
Self-citationGlutathione‐Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy
Zhang, L., Zhu, L., Tang, L., Xie, J., Gao, Y., Yu, C., Shang, K., Han, H., Liu, C., & Lu, Y. (2022) · Advanced Science · doi:10.1002/advs.202205246 · Cited by 65
Self-citationCopper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma
Li, Y., Yang, J., Zhang, Q., Xu, S., Sun, W., Ge, S., Xu, X., Jager, M. J., Jia, R., Zhang, J., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02364-0 · Cited by 63
Unraveling and Overcoming Platinum Drug‐Resistant Cancer Tumors with DNA Nanostructures
Yu, Y., Zhang, L., Qin, Z. S., Karges, J., Xiao, H., & Su, X. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202208797 · Cited by 62
Self-citationNIR-II light evokes DNA cross-linking for chemotherapy and immunogenic cell death
Huang, Y. H., Wei, D., Wang, B., Tang, D., Cheng, A., Xiao, S., Yu, Y., & Huang, W. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.02.012 · Cited by 60
Song, H., Cai, Z., Li, J., Xiao, H., Qi, R., & Zheng, M. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01531-5 · Cited by 58
Self-citationQu, Y., Sun, Z., Han, W., Zou, Q., Xing, N., Luo, H., Zhang, X., He, C., Bian, X., Cai, J., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004427 · Cited by 32
Self-citationImmune Checkpoint Inhibitors in Front-line Therapy for Urothelial Cancer
Szabados, B. E., Prendergast, A., Jackson‐Spence, F., Choy, J., & Powles, T. B. (2021) · European Urology Oncology · doi:10.1016/j.euo.2021.02.010 · Cited by 19
Cited by
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Lu, Q., Kou, D., Lou, S., Ashrafizadeh, M., Aref, A. R., Canadas, I., Tian, Y., Niu, X., Wang, Y., Torabian, P., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01535-8 · Cited by 373
Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer
Wang, W., Lu, K., Jiang, X., Wei, Q., Zhu, L., Wang, X., Jin, H., & Feng, L. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02720-2 · Cited by 300
Self-citationZhang, M., Liu, C., Tu, J., Tang, M., Ashrafizadeh, M., Nabavi, N., Sethi, G., Zhao, P., & Liu, S. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02305-x · Cited by 259
Metadata
- Authors
- Guo, B., Yang, F., Zhang, L., Zhao, Q., Wang, W., Yin, L., Chen, D., Wang, M., Han, S., Xiao, H., & Xing, N.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2023-04-02
- Volume
- 35
- Issue
- 22
- Pages
- e2212267-e2212267
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W4324129884
- Cited by
- 391
- References
- 47
- FWCI
- 29.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.